AbCellera Biologics (ABCL) Revenue (QoQ) (2020 - 2026)
AbCellera Biologics (ABCL) Revenue (QoQ) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
AbCellera Biologics |
1.61 Bn |
1.51 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-81.46% |
| Dec 31, 2025 |
400.87% |
| Sep 30, 2025 |
-47.58% |
| Jun 30, 2025 |
303.40% |
| Mar 31, 2025 |
-16.14% |
| Dec 31, 2024 |
-22.39% |
| Sep 30, 2024 |
-11.14% |
| Jun 30, 2024 |
-26.43% |
| Mar 31, 2024 |
8.44% |
| Dec 31, 2023 |
39.10% |
| Sep 30, 2023 |
-34.38% |
| Jun 30, 2023 |
-17.52% |
| Mar 31, 2023 |
-43.41% |
| Dec 31, 2022 |
-78.75% |
| Sep 30, 2022 |
120.80% |
| Jun 30, 2022 |
-85.50% |
| Mar 31, 2022 |
127.22% |
| Dec 31, 2021 |
2,429.61% |
| Sep 30, 2021 |
-80.07% |
| Jun 30, 2021 |
-86.37% |
